| CAS: | 525596-64-9 | ||
| 中文名称: |
| ||
| 英文名称: |
|
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||||||||||||||||||
| SML0182 | Sigma-Aldrich | bPiDl hydrate | ≥98% (HPLC) | 1480.38元/10 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||
产品说明 应用 bPiDl hydrate may be used to study nicotinic receptor-mediated signaling. 包装 10 mg in glass bottle 生化/生理作用 bPiDI is an α6β2-specific antagonist that inhibits nicotine-evoked and endogenous dopamine release from rat striatal slices (IC50 = 150 nM, Imax = 55%). bPiDI treatment decreases nicotine self-administration, and nicotine-induced locomotor activity in rats. 特点和优势 This compound is featured on the Acetylcholine Receptors (Nicotinic) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||